J9326 HCPCS Level II code: Injection, telisotuzumab vedotin-tllv, 1 mg
J9326 is the HCPCS code for “Injection, telisotuzumab vedotin-tllv, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9326Injection, telisotuzumab vedotin-tllv, 1 mg
Short description: Telisotuzumab vedotin-tllv
HCPCS · United States
Medicare details
The indicators CMS publishes with J9326 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jan 1, 2026
Where J9326 sits
- 1J codesDrugs administered other than orally
- 2Active code J9326Injection, telisotuzumab vedotin-tllv, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9326 mean?
J9326 is the HCPCS code for “Injection, telisotuzumab vedotin-tllv, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9326?
CMS lists J9326’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9326
All J codesJ9320Injection, streptozocin, 1 gramJ9321Injection, epcoritamab-bysp, 0.16 mgJ9322Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mgJ9323Injection, pemetrexed ditromethamine, 10 mgJ9324Injection, pemetrexed (pemrydi rtu), 10 mgJ9325Injection, talimogene laherparepvec, per 1 million plaque forming unitsJ9328Injection, temozolomide, 1 mgJ9329Injection, tislelizumab-jsgr, 1mgJ9330Injection, temsirolimus, 1 mgJ9331Injection, sirolimus protein-bound particles, 1 mgJ9332Injection, efgartigimod alfa-fcab, 2mgJ9333Injection, rozanolixizumab-noli, 1 mg